Medical Device Cleaning Market: as sterile processing departments shift from being treated as a hospital cost centre into being measured as compliance-critical infrastructure, washer-disinfector platforms are converting from single-purpose cleaning hardware into connected, resource-adaptive systems that document every cycle for audit readiness, so equipment purchasing decisions increasingly weigh utility efficiency and digital traceability alongside raw throughput, and vendors that pair automation hardware with software-based cycle documentation are capturing the sterile processing modernisation budget that pure hardware replacement cycles previously did not unlock.

The global medical device cleaning market size was USD 2.49 Billion in 2025 and is expected to register a revenue CAGR of 6.8% during the forecast period. Market revenue growth is driven by factors such as sterile processing departments increasingly being measured on compliance documentation and audit readiness rather than throughput alone, the shift toward utility-efficient washer-disinfector technology that automatically adjusts resource consumption to load size, and continued automation of the physical logistics surrounding instrument cleaning within central sterile supply departments. The first driving factor is the growing treatment of sterile processing departments as compliance-critical infrastructure rather than a hospital cost centre, requiring cleaning equipment capable of documenting every cycle for audit and traceability purposes. Sterile processing departments play a central role in infection prevention, and hospitals face increasing scrutiny over cycle validation, traceability, and accreditation readiness, converting cleaning equipment procurement into a compliance investment decision rather than a purely operational one. The second driving factor is the shift toward utility-efficient washer-disinfector technology that automatically adjusts water and detergent use to the actual load being processed, reducing both operating cost and environmental impact. Getinge launched Aquadis 44, a washer-disinfector featuring adaptive water filling that automatically adjusts the amount of water and detergent based on load size, directly addressing hospital pressure to reduce environmental impact and total cost of ownership without compromising cleaning performance. The third driving factor is continued automation of the physical logistics surrounding instrument cleaning within central sterile supply departments, extending automation beyond the washer-disinfector itself into instrument transport and workflow coordination. These are some of the key factors driving revenue growth of the market.

A second layer of demand comes from the way a single automated logistics platform widens its own addressable value as it integrates with a hospital’s existing washer-disinfector and sterilizer installed base, letting one coordinated automation investment capture value across an entire central sterile supply department workflow rather than improving a single piece of equipment in isolation. Once a central sterile supply department invests in automated instrument transport and workflow coordination technology, extending that same automation layer to interface with the department’s already-installed washer-disinfectors and sterilizers compounds the value of the initial investment without requiring each individual piece of cleaning equipment to be replaced, so the value of automation investment grows as it spans a department’s full workflow rather than a single station. As a result, demand and revenue share are concentrating around vendors offering connected, workflow-level automation rather than standalone washer-disinfector hardware alone, and the forecast tilts toward integrated cleaning-and-logistics ecosystems rather than single-purpose cleaning equipment sold independently. For instance, in December 2025, Getinge, Sweden, unveiled Automatiq, a new family of next-generation automated solutions combining smart robotics, intelligent conveyor systems, and advanced software, with loader modules specifically compatible with the company’s existing 8668 Washer-Disinfector and GSS67H Steam Sterilizer platforms, extending workflow-level automation value across a hospital’s already-installed cleaning equipment base rather than requiring a full hardware replacement. These are some of the key factors driving revenue growth of the market.

The clearest driver of demand is the growing treatment of sterile processing departments as compliance-critical infrastructure requiring documented, auditable cleaning cycles rather than simply functional equipment. Hospital accreditation and infection control audits increasingly require documented proof that every cleaning cycle met validated parameters, and this requirement works only if cleaning equipment itself can capture and export that documentation automatically, so compliance scrutiny and demand for cycle-documenting cleaning equipment are directly linked. Sterile processing departments play a central role in infection prevention, and hospitals face increasing scrutiny over cycle validation, traceability, and accreditation readiness, a scrutiny level that has converted cleaning equipment specification from a purely operational throughput decision into a compliance-driven procurement requirement. The effect on the market is that washer-disinfector purchasing decisions increasingly weight documentation and traceability capability alongside cleaning performance and throughput. These are some of the key factors driving revenue growth of the market.

The second driver is the shift toward washer-disinfector technology that automatically adapts resource consumption to the actual load being processed rather than using a fixed resource allocation regardless of load size. Hospitals face simultaneous pressure to reduce both operating cost and environmental footprint, and adaptive resource technology addresses both goals with a single engineering solution rather than requiring a trade-off between them, so utility-adaptive design and dual-pressure hospital purchasing criteria are directly linked. Getinge launched Aquadis 44 in November 2025, a washer-disinfector featuring adaptive water filling that automatically adjusts the amount of water and detergent based on load size, delivering lower total cost of ownership alongside reduced utility consumption and CO2 footprint. The recent record shows the pace. Getinge also introduced a new version of its Solsus 66 Steam Sterilizer, built on more than two decades of established technology heritage, designed to meet the evolving compliance and efficiency needs of central sterile supply departments. The effect on the market is that utility-adaptive resource technology has become a genuine competitive differentiator in washer-disinfector procurement, not simply a marketing feature layered onto conventional equipment. These are some of the key factors driving revenue growth of the market.

“Getinge’s Automatiq platform, unveiled in December 2025, combines smart robotics, intelligent conveyor systems, and advanced software with loader modules specifically compatible with the company’s existing 8668 Washer-Disinfector and GSS67H Steam Sterilizer, extending automation value across a hospital’s already-installed cleaning equipment rather than requiring a full hardware replacement.”

The third driver is the extension of automation beyond the cleaning device itself into the physical logistics of moving instruments through a sterile processing department. Manual instrument handling within a sterile processing department creates ergonomic strain and workflow bottlenecks for staff, and automated transport and loading technology directly addresses this operational constraint in a way that improving the washer-disinfector alone cannot, so workflow-level automation and department-wide efficiency gains are directly linked. Getinge unveiled Automatiq in December 2025, a new family of next-generation automated solutions combining smart robotics, intelligent conveyor systems, and advanced software, with modules including a self-navigating mobile robot for instrument transport and loader modules compatible with the company’s existing washer-disinfector and steam sterilizer platforms. The effect on the market is that automation investment is increasingly evaluated at the department-workflow level rather than the individual-equipment level, favouring vendors who can offer coordinated automation across transport, cleaning, and sterilization stages. These are some of the key factors driving revenue growth of the market.

However, the medical device cleaning market faces adoption constraints from the capital cost of upgrading to connected, utility-efficient washer-disinfector and automation technology, the skilled-labour and training requirements that sterile processing department compliance increasingly demands, and facility infrastructure compatibility limitations for the newest automated workflow systems. Because connected, resource-adaptive washer-disinfector and workflow automation technology carries a meaningful cost premium over standard cleaning equipment, reflecting the more sophisticated sensor, software, and robotics engineering required, hospital capital budget constraints continue to limit the pace at which sterile processing departments can upgrade their full equipment fleet, even where the compliance documentation and utility-efficiency case for doing so is well established, meaning realised technology adoption lags the underlying case for it. Sterile processing workforce and training requirements are a second constraint, because increasingly sophisticated, connected cleaning and documentation systems require staff trained on both the physical equipment operation and the compliance documentation workflow it supports, and sterile processing departments already facing broader healthcare staffing pressures may struggle to allocate the dedicated training time that new connected equipment requires to be used to its full compliance-supporting capability. Facility infrastructure compatibility is the third constraint, since retrofitting a hospital’s existing central sterile supply department layout to accommodate automated conveyor and robotic transport systems such as Getinge’s Automatiq requires physical space, power, and workflow redesign planning that not every existing facility, particularly older buildings with fixed floor plans, can readily accommodate without a broader facility renovation project. These factors substantially limit medical device cleaning market growth over the forecast period.

Based on process, the global medical device cleaning market is segmented into manual cleaning, automated washer-disinfection, and ultrasonic cleaning. Automated washer-disinfection holds the largest revenue share, because it represents the highest-value capital equipment category and the primary focus of connected, compliance-documenting technology investment, which suits Getinge’s and STERIS’s core washer-disinfector product strategy. Manual cleaning remains established as a required first step in most reprocessing workflows regardless of subsequent automated processing, and ultrasonic cleaning serves specific delicate and cannulated instrument applications, but neither matches automated washer-disinfection’s overall revenue scale. Ultrasonic cleaning is expected to register rapid revenue growth in the global medical device cleaning market over the forecast period, driven by expanding use for complex laparoscopic and robotic-assisted surgical instrument cleaning, which is why manufacturers continue to expand ultrasonic cleaner capacity and chemistry compatibility.

Based on device, the global medical device cleaning market is segmented into critical devices (surgical instruments), semi-critical devices (endoscopes), and non-critical devices. Critical devices hold a significant revenue share, reflecting the highest sterility assurance requirements and correspondingly rigorous cleaning validation standards applied to surgical instruments entering sterile body cavities. Semi-critical devices, particularly endoscopes, are expected to register rapid revenue growth in the global medical device cleaning market over the forecast period, driven by continued FDA and hospital scrutiny of endoscope reprocessing following well-documented infection risk concerns, which is why HOYA and Getinge both continue investing in endoscope-specific reprocessing technology.

Hospital sterile processing departments application is expected to account for the largest revenue share in the global medical device cleaning market during the forecast period

Based on application, the global medical device cleaning market is segmented into hospital sterile processing departments, biopharmaceutical cGMP cleanrooms, and ambulatory surgical centres. Hospital sterile processing departments hold the largest revenue share, reflecting the sheer scale of surgical instrument reprocessing volume that hospital-based sterile processing departments handle daily across all surgical specialties. Biopharmaceutical cGMP cleanrooms are expected to register rapid revenue growth in the global medical device cleaning market over the forecast period, driven by Getinge’s continued investment in cleanroom-specific washer and sterilizer interface technology, which is why life science manufacturing represents a growing application category distinct from traditional hospital reprocessing.

Based on regional analysis, the medical device cleaning market in North America accounted for largest revenue share in 2025. The United States leads because it hosts the largest concentration of hospital sterile processing departments subject to rigorous accreditation and infection control audit requirements, and because STERIS and Getinge both concentrate significant commercial and product development activity in the country. STERIS plc’s continued tuck-in acquisition activity, including approximately USD 15.0 million in Healthcare segment acquisitions during the first half of fiscal year 2026, reinforces the scale of the company’s continued United States market investment. The concentration of hospital accreditation and infection control compliance activity in the United States also means new connected and compliance-documenting cleaning technology is typically adopted in the United States first.

The market in Europe is expected to register a steady revenue growth rate over the forecast period. Germany, the United Kingdom, and France represent the three largest national medical device cleaning markets within Europe. Getinge, headquartered in the region, maintains deep installed relationships across European hospital sterile processing departments, and the region’s established sterile processing infrastructure and CE-marking regulatory pathway under the Medical Device Regulation sustain steady demand. The result is steady rather than rapid growth, shaped more by the region’s already-mature sterile processing infrastructure than by unmet compliance demand.

The market in Asia Pacific is expected to register a rapid revenue growth rate over the forecast period. China, Japan, and India represent the three largest national medical device cleaning markets within the region. Expanding hospital infrastructure investment and rising surgical procedure volumes in China and India are driving new cleaning equipment demand from a comparatively lower installed base, leaving more room for growth than in the already-mature North America and Europe markets.

The market in Latin America is expected to register a moderate revenue growth rate over the forecast period. Brazil and Mexico represent the two largest national medical device cleaning markets within the region. Hospital sterile processing departments in both countries are gradually adopting more advanced automated washer-disinfection technology, and the indirect effects of Iran-US sanctions and the associated Strait of Hormuz shipping disruption have kept freight and import costs elevated for the specialised washer-disinfector systems and reprocessing chemistries that Latin American hospitals depend on through 2026, slowing adoption beyond the region’s main urban hospital networks.

The market in Middle East and Africa is expected to register a moderate revenue growth rate over the forecast period. Saudi Arabia and the UAE represent the primary commercial medical device cleaning markets within the GCC. The UAE is the most established medical device cleaning market on the continent given its concentrated private hospital infrastructure, while the wider Gulf states and broader African markets are still building the sterile processing infrastructure and compliance culture that advanced cleaning technology adoption depends on.